ChemDAQ partners with customers to facilitate compliance with EPA FIFRA Interim Decision on Ethylene Oxide

, /PRNewswire/ -- In January, the U.S. Environmental Protection Agency (EPA) released its interim decision under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) regarding the use of ethylene oxide (EtO) for medical device sterilization. This decision imposes stricter requirements on sterilization facilities to mitigate health risks associated with EtO exposure. ChemDAQ, a leader in hazardous gas monitoring solutions, is poised to help sterilization facilities and associated warehousing operations comply with these new regulations, ensuring worker safety and regulatory compliance.

The EPA's interim decision introduces risk mitigation measures, including stricter exposure limits, enhanced monitoring, and increased reporting requirements. As EtO is a critical sterilant in the healthcare industry, these new mandates will require facilities to adopt advanced monitoring solutions to protect employees.

How ChemDAQ Supports Safety and Compliance in Sterilization Facilities and Warehouses
ChemDAQ's industry-leading EtO gas detection systems offer the latest sensor technologies and continuous innovation to give facilities the tools needed to comply with the EPA's requirements. Key benefits include:

• Continuous Fixed Monitoring: ChemDAQ's state-of-the-art monitoring systems provide continuous and simultaneous monitoring of EtO throughout facilities, ensuring immediate awareness of hazardous exposure levels.
• Portable Monitoring System: ChemDAQ's Personal Sampling System provides the capability for both spot checking and worker breathing zone monitoring.
• Regulatory Compliance: Facilities leverage ChemDAQ's monitoring solutions to generate accurate exposure reports for compliance with the EPA's new requirements.
• Worker Safety Assurance: Real-time and impending (predictive) alerts, along with continuous data logging, help mitigate risks, protecting employees from harmful exposure levels.
• Customizable Solutions: ChemDAQ's technology can be tailored to fit the specific needs of sterilization and warehouse facilities, ensuring seamless integration with existing operations.

"Our customers in the sterilization industry are critical to the supply of medical devices across the country and the world. As the regulatory landscape surrounding ethylene oxide evolves, our mission remains the same: to empower our customers to eliminate workplace exposure to toxic chemicals like EtO through innovative monitoring and control solutions, industry-leading partnerships, and superior safety expertise," said Alex Hilliker, Executive Vice President at ChemDAQ. "We are committed to working alongside medical device sterilization facilities to ensure their important work continues

without disruption, while also providing a safe work environment for all employees throughout the supply chain."

For more information on how ChemDAQ can help your facility comply with the new EPA regulations on EtO, visit ChemDAQ.com.

About ChemDAQ
ChemDAQ's mission is to empower customers to eliminate workplace exposure to toxic chemicals through innovative monitoring and control solutions, industry-leading partnerships, and superior safety expertise. ChemDAQ's industry-leading gas detection systems were initially deployed in US hospitals and medical device sterilization operations. The company has since expanded globally to serve more than 600 customers within the healthcare, medical device manufacturing, food and beverage packaging, and protein processing industries. To learn more about how ChemDAQ provides safer workplaces, less risk, and next-level protection, visit www.chemdaq.com.

SOURCE ChemDAQ